16 Sep Renown Health, DRI and 23andMe population health study expanded to 10,000 participants after unprecedented public interest
More than 5,000 people registered for a free DNA kit within the first 24 hours
RENO, Nev. (Sept. 16, 2016) – A ground-breaking community-based population health study launched yesterday by Nevada-based Renown Health, the Desert Research Institute (DRI) and 23andMe, a leading personal genetics company, has doubled its initial enrollment size.
Officials announced today that due to overwhelming public interest they have increased the pilot phase of the study to an additional 5,000, bringing total participants to 10,000.
“This is population health at its best,” said Anthony Slonim, M.D., DrPH, Renown Health president and CEO. “We honestly didn’t know how long it would take to enroll 5,000 people because this has never been done before.”
Lead DRI scientist on the study Joseph Grzymski, Ph.D., explained that public enrollment in the study had reached more than 5,000 people by Friday, less than 24 hours after the initial announcement.
Grzymski added that Renown Health and DRI research team members consented more than 250 people to participate in the pioneering study in less than one hour following a press conference that included Governor Brian Sandoval announcing his participation.
“Surpassing the enrollment goal in less than 24 hours is unheard of in research studies,” said Anne Wojcicki,” co-founder and CEO of 23andMe. “Treating people like partners in research and returning information back to participants is an incredible tool for driving participation and engagement.”
Nevada residents interested in participating can register online at partners.renown.org